Charles River Laboratories
251 Ballardvale St,
Wilmington, MA, USA 01887
T +1-877 2748371
E askcharlesriver@criver.com
W www.criver.com
.png?width=303&height=162&name=custom-cells-placeholder%20(3).png)
abcam
tebu-bio
39 Rue de Houdan-BP 15
78612, Le Perray-en-Yvelines, France
T+33-13046 3900
.png?width=303&height=162&name=custom-cells-placeholder%20(1).png)
Cedarlane Labs
4410 Paletta Court,
Burlington, Ontario, L7L 5R2, Canada
T +1-289 288 0001
E general@cedarlanelabs.com
W www.cedarlanelabs.com
Afirmus Biosource
2 Kallang Avenue,
#06-32, Singapore, 339407
T +65-66046872 / 81637412
E enquiry@afirmus.com
W www.afirmus.com
Cosmo Bio
Toyo Ekimae Bldg,
2-2-20, Toyo Koto-Ku, Tokyo 135-0016, Japan
T +81-35632 9610
E mail@cosmobio.co.jp
W www.cosmobio.co.jp
FoliBio Technology
5F, No. 200, Sec. 3,
Nanjing East Road, Taipei 10488, Taiwan
T +886-2273 19370
E info@folibio.com.tw
W www.folibio.com.tw
Komabiotech
1-1 Yangpyeongdong
Yeongdeungpo-gu, Seoul 07, South Korea
T +82-2579 8787
E order@komabiotech.co.kr
W www.komabiotech.co.kr
Pensa Bio
Rua Pinto Gonçalves,
84 Perdizes, São Paulo 05005-010, Brazil
T +55-113868 6500
E comercial@pensabio.com.br
W www.pensabio.com.br
Consistent cells at scale
Whether you need human cells in small batches or greater than a billion cells, quantity requirements can be specified to meet experimental needs using bit.bio’s wild type cells and/or disease models.
Guaranteed batch delivery
bit.bio offers blanket order options to provide recurring delivery of specific cells when you need them.
Custom disease models
bit.bio can create advanced human cell disease models by introducing or removing disease-causing mutations and/or associated reporter technologies into any bit.bio wild type cell type
In conversation with Charles River
bit.bio and Charles River Laboratories have partnered for translational drug development. Listen to Dr Marijn Vlaming, Head of Biology, Charles River Laboratories, discuss how ioCells are accelerating drug discovery and early-stage development.
“Making cells from iPSCs is a time - consuming activity and with the technology that bit.bio has developed it will become easier to generate different cell models”
Dr Marijn Vlaming
Head of Biology | Charles River Laboratories
